Cargando…
Opioid use disorder in two samples of the Lebanese population: scale validation and correlation with sleep and mood disorders
BACKGROUND: The revised Opioid Risk Tool (ORT-OUD) is a brief, self-report scale designed to provide clinicians with a simple, validated method to screen for the risk of developing an Opioid Use Disorder (OUD) in patients without a prior history of substance abuse. This study aimed to translate and...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619223/ https://www.ncbi.nlm.nih.gov/pubmed/37914993 http://dx.doi.org/10.1186/s12888-023-05304-8 |
_version_ | 1785129940119715840 |
---|---|
author | Chamoun, Karam Mouawad, Joseph Salameh, Pascale Sacre, Hala Haddad, Ramzi Khabbaz, Lydia Rabbaa Megarbane, Bruno Hajj, Aline |
author_facet | Chamoun, Karam Mouawad, Joseph Salameh, Pascale Sacre, Hala Haddad, Ramzi Khabbaz, Lydia Rabbaa Megarbane, Bruno Hajj, Aline |
author_sort | Chamoun, Karam |
collection | PubMed |
description | BACKGROUND: The revised Opioid Risk Tool (ORT-OUD) is a brief, self-report scale designed to provide clinicians with a simple, validated method to screen for the risk of developing an Opioid Use Disorder (OUD) in patients without a prior history of substance abuse. This study aimed to translate and validate the Arabic version of ORT-OUD in the Lebanese population and assess its clinical validity in a sample of patients with OUD. METHODS: This cross-sectional study in the Lebanese population used several validated scales to assess the risk of OUD, including the Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST). Other tools evaluated chronotype and sleep and mood disturbances. Principal component analysis with Varimax rotation was applied to assess ORT-OUD construct validity. Convergent validity with the Arabic version of ASSIST was evaluated. The ORT-OUD criterion validity was then assessed in a clinical sample of patients with OUD. RESULTS: This study included 581 participants. The prevalence of the OUD risk in the Lebanese population using the ORT-OUD scale and the ASSIST-opioids scale was estimated at 14.5% and 6.54%, respectively. No items of the ORT-OUD were removed; all items converged over a solution of four factors with an eigenvalue > 1, explaining a total of 68.2% of the variance (Cronbach’s alpha = 0.648). The correlation coefficients between the ORT-OUD total score and ASSIST subscales were as follows: ASSIST-opioids (r = 0.174; p = < 0.001), ASSIST-sedatives (r = 0.249; p < 0.001), and ASSIST-alcohol (r = 0.161; p = < 0.001). ORT-OUD clinical validation showed a correlation with ASSIST-opioids (r = 0.251; p = 0.093) and ASSIST-sedatives (r = 0.598; p < 0.001). Higher ORT-OUD scores were associated with a family and personal history of alcohol and substance consumption and higher insomnia and anxiety scores. CONCLUSIONS: This study is the first to validate the Arabic version of ORT-OUD in the Lebanese population, an essential step towards improving the detection and management of OUD in this population. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12888-023-05304-8. |
format | Online Article Text |
id | pubmed-10619223 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-106192232023-11-02 Opioid use disorder in two samples of the Lebanese population: scale validation and correlation with sleep and mood disorders Chamoun, Karam Mouawad, Joseph Salameh, Pascale Sacre, Hala Haddad, Ramzi Khabbaz, Lydia Rabbaa Megarbane, Bruno Hajj, Aline BMC Psychiatry Research BACKGROUND: The revised Opioid Risk Tool (ORT-OUD) is a brief, self-report scale designed to provide clinicians with a simple, validated method to screen for the risk of developing an Opioid Use Disorder (OUD) in patients without a prior history of substance abuse. This study aimed to translate and validate the Arabic version of ORT-OUD in the Lebanese population and assess its clinical validity in a sample of patients with OUD. METHODS: This cross-sectional study in the Lebanese population used several validated scales to assess the risk of OUD, including the Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST). Other tools evaluated chronotype and sleep and mood disturbances. Principal component analysis with Varimax rotation was applied to assess ORT-OUD construct validity. Convergent validity with the Arabic version of ASSIST was evaluated. The ORT-OUD criterion validity was then assessed in a clinical sample of patients with OUD. RESULTS: This study included 581 participants. The prevalence of the OUD risk in the Lebanese population using the ORT-OUD scale and the ASSIST-opioids scale was estimated at 14.5% and 6.54%, respectively. No items of the ORT-OUD were removed; all items converged over a solution of four factors with an eigenvalue > 1, explaining a total of 68.2% of the variance (Cronbach’s alpha = 0.648). The correlation coefficients between the ORT-OUD total score and ASSIST subscales were as follows: ASSIST-opioids (r = 0.174; p = < 0.001), ASSIST-sedatives (r = 0.249; p < 0.001), and ASSIST-alcohol (r = 0.161; p = < 0.001). ORT-OUD clinical validation showed a correlation with ASSIST-opioids (r = 0.251; p = 0.093) and ASSIST-sedatives (r = 0.598; p < 0.001). Higher ORT-OUD scores were associated with a family and personal history of alcohol and substance consumption and higher insomnia and anxiety scores. CONCLUSIONS: This study is the first to validate the Arabic version of ORT-OUD in the Lebanese population, an essential step towards improving the detection and management of OUD in this population. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12888-023-05304-8. BioMed Central 2023-11-01 /pmc/articles/PMC10619223/ /pubmed/37914993 http://dx.doi.org/10.1186/s12888-023-05304-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Chamoun, Karam Mouawad, Joseph Salameh, Pascale Sacre, Hala Haddad, Ramzi Khabbaz, Lydia Rabbaa Megarbane, Bruno Hajj, Aline Opioid use disorder in two samples of the Lebanese population: scale validation and correlation with sleep and mood disorders |
title | Opioid use disorder in two samples of the Lebanese population: scale validation and correlation with sleep and mood disorders |
title_full | Opioid use disorder in two samples of the Lebanese population: scale validation and correlation with sleep and mood disorders |
title_fullStr | Opioid use disorder in two samples of the Lebanese population: scale validation and correlation with sleep and mood disorders |
title_full_unstemmed | Opioid use disorder in two samples of the Lebanese population: scale validation and correlation with sleep and mood disorders |
title_short | Opioid use disorder in two samples of the Lebanese population: scale validation and correlation with sleep and mood disorders |
title_sort | opioid use disorder in two samples of the lebanese population: scale validation and correlation with sleep and mood disorders |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619223/ https://www.ncbi.nlm.nih.gov/pubmed/37914993 http://dx.doi.org/10.1186/s12888-023-05304-8 |
work_keys_str_mv | AT chamounkaram opioidusedisorderintwosamplesofthelebanesepopulationscalevalidationandcorrelationwithsleepandmooddisorders AT mouawadjoseph opioidusedisorderintwosamplesofthelebanesepopulationscalevalidationandcorrelationwithsleepandmooddisorders AT salamehpascale opioidusedisorderintwosamplesofthelebanesepopulationscalevalidationandcorrelationwithsleepandmooddisorders AT sacrehala opioidusedisorderintwosamplesofthelebanesepopulationscalevalidationandcorrelationwithsleepandmooddisorders AT haddadramzi opioidusedisorderintwosamplesofthelebanesepopulationscalevalidationandcorrelationwithsleepandmooddisorders AT khabbazlydiarabbaa opioidusedisorderintwosamplesofthelebanesepopulationscalevalidationandcorrelationwithsleepandmooddisorders AT megarbanebruno opioidusedisorderintwosamplesofthelebanesepopulationscalevalidationandcorrelationwithsleepandmooddisorders AT hajjaline opioidusedisorderintwosamplesofthelebanesepopulationscalevalidationandcorrelationwithsleepandmooddisorders |